#VisualAbstract: Semaglutide Improves Outcomes in Metabolic Dysfunction–Associated Steatohepatitis
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: metabolic dysfunction-associated steatotic liver disease
Aligos Therapeutics: ALG-055009 reduces liver fatty deposits in patients with metabolic-dysfunction associated steatohepatitis (MASH)
ALG-055009, a thyroid hormone receptor agonist, significantly reduced liver fat in patients with MASH after 12 weeks of treatment. ALG-055009 ...
#VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving MASH
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
#VisualAbstract: Aspirin reduces hepatic fat quantity in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) without Cirrhosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
